Tokio Marine Asset Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Tokio Marine Asset Management’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-994	Closed	-$242K	–	543
2025 Q1	$242K	Buy	994 +94	+10%	+$28.3K	0.01%	558
2024 Q4	$296K	Buy	900 +34	+4%	+$11.5K	0.01%	558
2024 Q3	$290K	Hold	866	–	–	0.01%	547
2024 Q2	$237K	Buy	866 +30	+4%	+$8.73K	0.01%	551
2024 Q1	$289K	Buy	836 +60	+8%	+$19.7K	0.01%	540
2023 Q4	$251K	Buy	776 +78	+11%	+$24.4K	0.01%	539
2023 Q3	$250K	Hold	698	–	–	0.02%	528
2023 Q2	$265K	Buy	698 +78	+13%	+$31.7K	0.02%	506
2023 Q1	$297K	Buy	620 +94	+18%	+$44K	0.02%	468
2022 Q4	$221K	Buy	+526	New	+$212K	0.02%	509
2022 Q3	–	Sell	-405	Closed	-$200K	–	505
2022 Q2	$200K	Buy	+405	New	+$211K	0.02%	490
2022 Q1	–	Sell	-283	Closed	-$214K	–	507
2021 Q4	$214K	Buy	+283	New	+$212K	0.02%	481

Other funds holding BIO

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

FPA

First Pacific Advisors El Segundo, California $7.14B AUM 21.51% 1-Year Est. Return

Tokio Marine Asset Management's BIO Position: Q2 2025 in Review

Tokio Marine Asset Management sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2025, closing a stake of 994 shares — an estimated $242K sold.

Tokio Marine Asset Management first reported a position in BIO in Q4 2021 and held it in 12 quarters. The position peaked at $297K in Q1 2023. 383 funds tracked by Wall St. Rank hold BIO as of Q2 2025.

Tokio Marine Asset Management reported no remaining Bio-Rad Laboratories Class A position as of Q2 2025 after selling out during the quarter.
Tokio Marine Asset Management sold 994 Bio-Rad Laboratories Class A shares in Q2 2025, an estimated $242K.
Tokio Marine Asset Management first reported a position in Bio-Rad Laboratories Class A in Q4 2021 and held it in 12 quarters.
Tokio Marine Asset Management's Bio-Rad Laboratories Class A position peaked at $297K in Q1 2023.
383 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2025.

Based on Tokio Marine Asset Management's 13F filing for Q2 2025, filed 12 Aug 2025.